Abstract
The expanding array of new type 2 diabetes agents and how to combine them effectively is complex. This review gives an overview of the newer therapies and their current place in type 2 diabetes management. It also examines the role of HbA 1c in the screening and diagnosis of those at risk of diabetes.
Cite
CITATION STYLE
APA
Chatterjee, S., & Davies, M. (2015). Type 2 diabetes: recent advances in diagnosis and management. Prescriber, 26(10), 15–21. https://doi.org/10.1002/psb.1355
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free